ML188 is a Potent Noncovalent Small Molecule Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease. The X-ray structure of SARS-CoV 3CLpro bound with ML188 was instrumental in guiding subsequent rounds of chemistry optimization. ML188 provides an excellent starting point for the further design and refinement of 3CLpro inhibitors that act by a noncovalent mechanism of action.
SARS-CoV Inhibitors Related Products:
Nafamostat; Nafamostat mesylate; PF-07321332; PLpro inhibitor; PF-00835231; Molnupiravir N-1; Molnupiravir